Schiff's Base of Different Sulfonamides

Schiff’s bases of sulfonamides represent a vital class of biologically active compounds with diverse pharmacological applications. Sulfonamides, initially developed as potent antibacterial agents, have been modified through Schiff’s base formation to enhance their therapeutic potential while minimizing adverse effects. Schiff’s bases, also known as azomethines (-C=N-), are synthesized by condensing sulfonamide derivatives with aldehydes or ketones under controlled reaction conditions. These compounds exhibit remarkable structural versatility, allowing them to form stable metal complexes with transition metals such as Cu, Co, Ni, and Zn. The chelation of Schiff’s base ligands with metal ions often results in enhanced bioactivity, attributed to increased lipophilicity and improved interactions with biological targets. This Article comprehensively discusses the synthesis, structural characterization, and pharmacological significance of Schiff’s bases derived from sulfonamides. Various synthetic strategies, including acid/base-catalyzed condensation and metal complexation, are explored alongside their spectroscopic characterization using FT-IR, NMR, and mass spectrometry. The biological activities of sulfonamide-based Schiff’s bases are critically evaluated, highlighting their antimicrobial, anticancer, anti-inflammatory, antitubercular, and antiviral properties. Studies indicate that Schiff’s bases exhibit superior pharmacological effects compared to their parent sulfonamides, particularly in their metal-coordinated forms. The findings underscore the potential of Schiff’s base metal complexes as promising candidates for drug development. Further research into their mechanism of action, pharmacokinetics, and clinical applications is necessary to optimize their therapeutic efficacy. This Article aims to provide valuable insights into the expanding role of Schiff’s bases in medicinal chemistry.